Power Alley | As US Pharma Companies See Uncertainty, Trump Continues His Decade-Long BS / Agitprop -- Demanding Drug Price Cuts -- By September 1, 2025: Impotent.

We've seen this damn dumb show before: in 2017, he said that all pharma companies would bow to him, and cut retail drug prices -- system wide -- for US consumers. . . by over 20%. In the space of three months (at August 2017). Then he imploded his own hand-picked industry-advisory council (as we copiously covered, in real time).

Obviously that "price cut" never happened. It took a Biden-led effort, through legislation and negotiations, to reach a government payor "right to negotiate" drug pricing. And that has, in the main, worked on the ten most widely prescribed US drugs. But now, again -- Tangerine says he will scrap that carefully crafted to be lawful measure. . . and simply "demand" (via a letter, of all things!) that all drugs in the US see a 30% price reduction -- by 09.01.2025. What a feckless idiot he is:

. . .Pharmaceutical stocks slumped, continuing a selloff that started with US-listed peers after President Donald Trump escalated his campaign to pressure drugmakers to lower prices in the US.

It is not at all clear that he has any authority to back his demands. . . .

And as it did with Mr. Biden, PhRMA is likely to. . . litigate the matter, in the federal courts -- which means he will be out of office, long before the suits are resolved, one way or the other at the Supremes.

Onward, grinning -- out, into a warm, lazy Friday afternoon at Pritzker Pavilion. Smile.

नमस्ते